INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
65 hedge funds and large institutions have $52.2M invested in Infinity Pharmaceuticals, Inc. in 2017 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 11 increasing their positions, 27 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
59% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 27
Holders
65
Holding in Top 10
–
Calls
$300K
Puts
$84K
Top Buyers
| 1 | +$7.28M | |
| 2 | +$3.86M | |
| 3 | +$2.38M | |
| 4 |
Millennium Management
New York
|
+$1.25M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$661K |
Top Sellers
| 1 | -$8.97M | |
| 2 | -$2.94M | |
| 3 | -$1.81M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$922K |
| 5 |
D.E. Shaw & Co
New York
|
-$561K |